Skip to main content

LCD L34209: Treatment of Varicose Veins of the Lower Extremities

LCD L34209, Treatment of Varicose Veins of the Lower Extremities, is the Local Coverage Determination that Noridian Healthcare Solutions, LLC applies to claims from 13 states plus 3 territories (AK, AS, AZ, CA, GU, HI, ID, MP and others), effective 2026-05-14 and first in force 2015-10-01. The policy text runs 892 words, and its billing and coding article A57706 lists 66 ICD-10-CM codes that support medical necessity for 26 procedure codes. 2 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 66 covered ICD-10-CM codes: 10 more codes than L34536 (Wisconsin Physicians Service Insurance Corporation, 56 codes, revised 2025-08-28) and 16 more codes than L39121 (Palmetto GBA, 50 codes, revised 2023-11-16).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Noridian Healthcare Solutions, LLC
States and territories
16
AK AS AZ CA CNMI GU HI ID MT ND NV OR SD UT WA WY
Revision effective
2026-05-14
Original effective
2015-10-01
Policy text
892 words
Covered ICD-10 codes (articles)
66

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34209
ContractContractorTypeStates
03201Noridian Healthcare Solutions, LLCA and B MACMT
03301Noridian Healthcare Solutions, LLCA and B MACND
03401Noridian Healthcare Solutions, LLCA and B MACSD
03501Noridian Healthcare Solutions, LLCA and B MACUT
03601Noridian Healthcare Solutions, LLCA and B MACWY
03102Noridian Healthcare Solutions, LLCA and B MACAZ
03202Noridian Healthcare Solutions, LLCA and B MACMT
03302Noridian Healthcare Solutions, LLCA and B MACND
03502Noridian Healthcare Solutions, LLCA and B MACUT
03602Noridian Healthcare Solutions, LLCA and B MACWY
03402Noridian Healthcare Solutions, LLCA and B MACSD
03101Noridian Healthcare Solutions, LLCA and B MACAZ
02201Noridian Healthcare Solutions, LLCA and B MACID
02101Noridian Healthcare Solutions, LLCA and B MACAK
02301Noridian Healthcare Solutions, LLCA and B MACOR
02401Noridian Healthcare Solutions, LLCA and B MACWA
02202Noridian Healthcare Solutions, LLCA and B MACID
02102Noridian Healthcare Solutions, LLCA and B MACAK
02402Noridian Healthcare Solutions, LLCA and B MACWA
02302Noridian Healthcare Solutions, LLCA and B MACOR
01111Noridian Healthcare Solutions, LLCA and B MACCA
01211Noridian Healthcare Solutions, LLCA and B MACAS CNMI GU HI
01311Noridian Healthcare Solutions, LLCA and B MACNV
01911Noridian Healthcare Solutions, LLCA and B MACAS CA CNMI GU HI NV
01112Noridian Healthcare Solutions, LLCA and B MACCA
01182Noridian Healthcare Solutions, LLCA and B MACCA
01212Noridian Healthcare Solutions, LLCA and B MACAS CNMI GU HI
01312Noridian Healthcare Solutions, LLCA and B MACNV

Billing and coding article A57706: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57706 (Billing and Coding: Treatment of Varicose Veins of the Lower Extremities) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57706: Billing and Coding: Treatment of Varicose Veins of the Lower Extremities (Billing and Coding, effective 2025-10-16)

Covered ICD-10-CM codes
66
1 group
Non-covered ICD-10-CM codes
3
Procedure codes listed
26
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57706
ICD-10-CMDescription (FY2027)
I80.01Phlebitis and thrombophlebitis of superficial vessels of right lower extremity
I80.02Phlebitis and thrombophlebitis of superficial vessels of left lower extremity
I80.03Phlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral
I83.011Varicose veins of right lower extremity with ulcer of thigh
I83.012Varicose veins of right lower extremity with ulcer of calf
I83.013Varicose veins of right lower extremity with ulcer of ankle
I83.014Varicose veins of right lower extremity with ulcer of heel and midfoot
I83.015Varicose veins of right lower extremity with ulcer other part of foot
I83.018Varicose veins of right lower extremity with ulcer other part of lower leg
I83.021Varicose veins of left lower extremity with ulcer of thigh
I83.022Varicose veins of left lower extremity with ulcer of calf
I83.023Varicose veins of left lower extremity with ulcer of ankle
I83.024Varicose veins of left lower extremity with ulcer of heel and midfoot
I83.025Varicose veins of left lower extremity with ulcer other part of foot
I83.028Varicose veins of left lower extremity with ulcer other part of lower leg
I83.11Varicose veins of right lower extremity with inflammation
I83.12Varicose veins of left lower extremity with inflammation
I83.211Varicose veins of right lower extremity with both ulcer of thigh and inflammation
I83.212Varicose veins of right lower extremity with both ulcer of calf and inflammation
I83.213Varicose veins of right lower extremity with both ulcer of ankle and inflammation
I83.214Varicose veins of right lower extremity with both ulcer of heel and midfoot and inflammation
I83.215Varicose veins of right lower extremity with both ulcer other part of foot and inflammation
I83.218Varicose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation
I83.221Varicose veins of left lower extremity with both ulcer of thigh and inflammation

Procedure codes: 36299, 36465, 36466, 36470, 36471, 36473, 36474, 36475, 36476, 36478, 36479, 36482, 36483, 37700, 37718, 37722, 37735, 37760, 37761, 37765, 37766, 37780, 37785, 37799, 93970, 93971.

Coverage indications, limitations and medical necessity

Varicose veins are caused by venous insufficiency as a result of valve reflux (incompetence). The venous insufficiency results in dilated, tortuous, superficial vessels that protrude from the skin of the lower extremities. Spider veins (telangiectasias) are dilated capillary veins that are most often treated for cosmetic purposes. Treatment of telangiectasias is not covered by Medicare.

Historically, varicose veins have been treated by conservative measures such as exercise, periodic leg elevation, weight loss, compressive therapy and avoidance of prolonged immobility. When conservative measures are unsuccessful, and symptoms persist, the next step has been sclerotherapy or surgical ligation with or without stripping. Sclerotherapy involves the injection of a sclerosing solution into the varicose vein(s).

Compressive sclerotherapy is the injection of the sclerosant into an empty vein (elevated limb) followed by application of a compressive bandage or dressing. This is the most commonly performed sclerotherapy procedure for varicose veins of the lower extremity. Compressive sclerotherapy is indicated for local small to medium symptomatic varices, isolated incompetent perforators, or recurrence of symptomatic varices after adequate surgical removal of varices. It is not considered an appropriate option for large, extensive or truncal varicosities. Foam sclerotherapy is FDA indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities of the great saphenous vein (GSV) system above and below the knee. It is usually given with ultrasound guidance. Non-Compressive sclerotherapy is not covered by Medicare.

More recently, endoluminal radiofrequency ablation (ERFA) and endoluminal laser ablation have been developed as alternatives to sclerotherapy and surgical intervention. These procedures are designed to damage the intimal wall of the vein resulting in fibrosis and subsequent ablation of the lumen of a segment of the vessel. Both procedures utilize specially designed catheters inserted through a small incision in the distal thigh and advanced, often under ultrasound guidance, nearly to the saphenofemoral junction. The catheter is then slowly withdrawn while controlled radiofrequency or laser energy is applied. This is followed by external compression of the treated segment.

Doppler ultrasound or duplex studies are often used to map the anatomy of the venous system prior to the procedure. There is adequate evidence that pre-procedural ultrasound is helpful, and Medicare will cover one ultrasound or duplex scan prior to the procedure to determine the extent and configuration of the varicosities.

Evidence and clinical experience supports the use of ultrasound guidance during the procedure (ERFA and laser ablation only) and shows that the outcomes may be improved and complication rates may be minimized when ultrasound guidance is used. The CPT codes for radiofrequency and laser include the intraoperative ultrasound service in the valuation and ultrasound may not be billed separately with these procedures.

In contrast to ERFA and laser procedures, intra-operative ultrasound guidance techniques have not been shown to increase the effectiveness or safety of sclerotherapy for varicose veins, therefore, intra-operative ultrasound guidance will not be separately covered for sclerotherapy.

A. Indications for surgical treatment: For example venous ligation, vein stripping and/or sclerotherapy:

1. A 3-month trial of conservative therapy such as exercise, periodic leg elevation, weight loss, compressive therapy, and avoidance of prolonged immobility where appropriate, has failed, AND

2. The patient is symptomatic and has one, or more, of the following:

a. Pain or burning in the extremity severe enough to impair mobility

b. Recurrent episodes of superficial phlebitis

c. Non-healing skin ulceration

d. Bleeding from a varicosity

e. Stasis dermatitis

f. Refractory dependent edema

B. Indications for ERFA or laser ablation :

In addition to the above (see A), the patient's anatomy and clinical condition are amenable to the proposed treatment including ALL of the following:

1. Absence of aneurysm in the target segment.

2. Maximum vein diameter of 12 mm for ERFA or 20 mm for laser ablation

3. Absence of thrombosis or vein tortuosity, which would impair catheter advancement. –4. The absence of significant peripheral arterial diseases.

C. Limitations for ERFA and laser ablation:

1. ERFA and laser ablation are covered only for the treatment of symptomatic varicosities of the lesser or greater saphenous veins and their tributaries which have failed 3 months of conservative therapy.

2. Intra-operative ultrasound guidance is not separately payable with ERFA, laser ablation, and sclerotherapy.

3. The treatment of asymptomatic varicose veins, or symptomatic varicose veins without a 3-month trial of conservative measures, by any technique will be considered cosmetic and therefore not covered.

4. The treatment of spider veins or superficial telangiectasis by any technique is considered cosmetic, and therefore not covered.

5. Coverage is only for devices specifically FDA-approved for these procedures.

6. One pre-operative Doppler ultrasound study or duplex scan will be covered.

Noridian notes that stab phlebectomy of the same vein performed on the same day as endovenous radiofrequency or laser ablation may be covered if the criteria for reasonable and necessary as described in this LCD are met.

Noridian notes that if sclerotherapy is used with endovenous radiofrequency ablation, it may be covered if the criteria for reasonable and necessary as described in this LCD are met.

Noridian will not consider the treatment of asymptomatic veins with endoluminal ablation or sclerotherapy medically reasonable and necessary. If it is determined on review that the varicose veins were asymptomatic, the claim will be denied as a noncovered (cosmetic) procedure.

Compliance with the provisions in this policy is subject to monitoring by post payment data analysis and subsequent medical review.

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-05-14
Last reviewed by the contractor
2026-05-05
MCD version
43
Derived from
L33497

Other related documents: A53084 (Billing and Coding), A54713 (Response to Comments), A54715 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Noridian Healthcare Solutions, LLC hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

Prior authorization in Original Medicare

  • Hospital outpatient departments need prior authorization nationwide for dates of service on or after July 1, 2020; it is a condition of payment for the hospital claim and related claims. CMS service group: Vein ablation and related services. Codes on the CMS list: 36473, 36474, 36475, 36476, 36478, 36479, 36482 and 36483.
  • Ambulatory surgical centers in the CMS prior authorization demonstration: January 19, 2026 in California, Florida, Georgia, Maryland, New York, Pennsylvania and Tennessee; February 16, 2026 in Arizona, Ohio and Texas; requests are voluntary, and claims without one go to pre-payment review. CMS service group: Vein ablation and related services. Codes on the CMS list: 36473, 36475, 36478 and 36482; 36474, 36476, 36479 and 36483 were removed on January 1, 2026.

Medicare Advantage plans run their own prior authorization lists. See the services and codes on the Medicare prior authorization list.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L34209 cover?

Varicose veins are caused by venous insufficiency as a result of valve reflux (incompetence). The venous insufficiency results in dilated, tortuous, superficial vessels that protrude from the skin of the lower extremities. Spider veins (telangiectasias) are dilated capillary veins that are most often treated for cosmetic purposes. Treatment of telangiectasias is not covered by Medicare. The full 892-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L34209 apply to?

Noridian Healthcare Solutions, LLC applies it to Medicare claims in 13 states plus 3 territories: AK, AS, AZ, CA, GU, HI, ID, MP, MT, ND, NV, OR, SD, UT, WA, WY. It binds only that contractor; 2 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34209?

The companion billing and coding article A57706 lists 66 ICD-10-CM codes in 1 group that support medical necessity and 3 that do not; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L34209?

A denial under LCD L34209 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57706's 66 covered diagnosis codes, then file a redetermination with Noridian Healthcare Solutions, LLC within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.